Regencell Bioscience Holdings Ltd.
We are an early-stage bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”) and Autism Spectrum Disorder (“ASD”). (Incorporated in the Cayman Islands) Our goal is to improve the lives of ADHD and ASD patients, their […]
July 16, 2021 Read More